Search for: "*nelson v. United Credit Plan" Results 21 - 38 of 38
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2012, 3:54 am by Rob Robinson
Compiled from online public domain resources, provided for your review/use is this week's update of key industry news, views, and events highlighting key electronic discovery related stories, developments, and announcements.For a live daily view of industry news, click here for the Vendor Clips Live News Feed.Follow @InfoGovernanceeDiscovery News Content and ConsiderationsCourt Orders Retention of Outside Vendor to Collect Responsive Documents, Investigate Possible Spoliation –… [read post]
19 Sep 2012, 5:40 am by Rob Robinson
 http://bit.ly/Q3mYPY (Dennis Kiker) States Enacting Rules on Use of Electronic Data in Medical Liability Cases – http://bit.ly/NztMYc (IHealthBeat) Technology Review: A FrameWork for Managing People, Technology and Processes - http://bit.ly/NrQlhv (Lynn Frances) Tips for Identifying and Preserving ESI – http://bit.ly/OXF9Xj (James Bernard, Michael Quartararo, Jason Vinokur) Twitter Contempt Sanctions Increase Need for Social Media Governance Plan… [read post]
12 Mar 2012, 8:13 am by Ronald Collins
Taft, Liberty Under Law, An Interpretation of the Principles of Our Constitutional Government (1922) Robert Houghwout Jackson, Full Faith and Credit, the Lawyer’s Clause of the Constitution (1945) Hugo L. [read post]
7 Jul 2010, 11:07 am by R. Grace Rodriguez, Esq.
Johnson forAmici Curiae United Trustee’s Association and California Mortgage Association.Leland Chan for Amicus Curiae California Bankers Association.I. [read post]
25 Feb 2010, 10:57 am by admin
Click Here California to Withdraw Harmful “Carbon Credits for Clearcuts” Forest Policy. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]